Rallybio (RLYB)

• Market cap: $27.9M
• 1 day: -4.2%
• 5 days: 2.94%
• 1 month: 18.27%
• 3 months: 26.29%
• 6 months: 108.46%
• Year to date: -29.69%
• 1 year: -34.5%
• 5 years: -95.26%
• 10 years: -95.26%
• Sector: Healthcare
• Industry: Biotechnology

About: Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Employees: 20